Physician profile
Ellen Pikus
NPI 1043950835
$763.34
in general payments reported to CMS, 2019-2025
11 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.17 · 2023: $254 · 2024: $54.22 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584 · Education: $95.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.22 |
| Education | $95.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $190.84 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $158.17 | 2023-2025 | Farxiga, Tagrisso |
| Regeneron Healthcare Solutions, INC. | $116.86 | 2025 | Libtayo |
| Seagen INC. | $95.95 | 2025 | |
| Alexion Pharmaceuticals, INC. | $49.93 | 2022-2023 | Ultomiris |
| Aurinia Pharma U.S., INC. | $42.13 | 2023-2024 | Lupkynis |
| E.R. Squibb & Sons, L.L.C. | $41.62 | 2022-2023 | Camzyos |
| Chiesi USA, INC. | $23.90 | 2024 | Cleviprex |
| Dexcom, INC. | $15.98 | 2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $14.59 | 2024 | Cologuard Collection Kit |
| Sk Life Science, INC. | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Pikus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.